C-reactive protein as the biomarker of choice to monitor the effects of exercise on inflammation in Parkinson’s disease

Parkinson’s disease (PD), a heterogeneous disease with no disease-modifying treatments available, is the fastest growing neurological disease worldwide. Currently, physical exercise is the most promising treatment to slow disease progression, with evidence suggesting it is neuroprotective in animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Niyati, Luthra, Nijee S., Corcos, Daniel M., Fantuzzi, Giamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213511/
https://www.ncbi.nlm.nih.gov/pubmed/37251392
http://dx.doi.org/10.3389/fimmu.2023.1178448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213511/
https://www.ncbi.nlm.nih.gov/pubmed/37251392
http://dx.doi.org/10.3389/fimmu.2023.1178448

Ejemplares similares